Skip to main content
Log in

Effect of systemic steroids on ileal pouch-anal anastomosis in patients with ulcerative colitis

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

BACKGROUND: Long-term steroid therapy predisposes to postsurgical complications, especially in patients with inflammatory bowel disease. PURPOSE: This study was undertaken to determine incidence of early septic complications after ileal pouch-anal anastomosis (TPAA) in patients who are undergoing prolonged steroid therapy. METHODS: We reviewed charts of 692 patients undergoing restorative proctocolectomy and IPAA to treat ulcerative colitis. Incidence of early (within 30 days) septic complications and sepsis-related reoperations, in patients who were having high-dose (>20 mg of prednisone per day) and low-dose steroid therapy (<20 mg of prednisone per day) for more than one month before surgery, was compared with patients who were not receiving steroid therapy. Follow-up included an annual questionnaire and physical examination. RESULTS: Patients without steroid dose data recorded were excluded (n=21). Of the 671 remaining patients, 310 received no steroids, 169 received low-dose steroids, and 192 received high-dose steroids. These three groups were similar in gender composition, age at surgery, types of anastomosis (stapled or handsewn), and incidence of diabetes mellitus, peripheral vascular disease, and obesity. Early septic complications were found in 18 (6 percent), 14 (8 percent), and 12 (6 percent) patients without steroid therapy, those having low-dose steroid therapy, and those having high-dose steroid therapy (P =0.57), respectively. Sepsis-related reoperation rate (P =0.73) and number of sepsis-related pouch excisions (P =0.79) did not differ between groups. In patients undergoing IPAA without ileostomy, early septic complications were found in one (3.8 percent), two (20 percent), and five (50 percent) patients without steroid treatment, low-dose steroid therapy, and high-dose steroid therapy (P =0.004), respectively. CONCLUSION: In patients who are undergoing IPAA with diversion for ulcerative colitis, prolonged systemic steroid therapy before surgery is not associated with increased septic complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Reding R, Michel LA, Donckier J, De Canniere L, Jamart J. Surgery in patients on long-term steroid therapy: a tentative model for risk assessment. Br J Surg 1990;77:1175–8.

    PubMed  Google Scholar 

  2. Ehrlich PH, Hunt TK. Effects of cortisone and vitamin A on wound healing. Ann Surg 1968;167:324–8.

    PubMed  Google Scholar 

  3. Price LA. The effect of systemic steroids on ileorectal anastomosis in ulcerative colitis. Br J Surg 1968;55:840–1.

    Google Scholar 

  4. Schrock TR, Deveney CW, Dunphy JE. Factors contributing to leakage of colonic anastomoses. Ann Surg 1973;177:513–8.

    PubMed  Google Scholar 

  5. Morgenstern L, Yamakawa T, Ben-Shoshan M, Lippman H. Anastomotic leakage after low colonic anastomosis. Am J Surg 1972;123:104–9.

    PubMed  Google Scholar 

  6. Aszodi A, Ponsky JL. Effects of corticosteroid on healing of bowel anastomosis. Am Surg 1984;50:546–8.

    PubMed  Google Scholar 

  7. Dostal GH, Gamelli RL. The differential effect of corticosteroids on wound disruption strength in mice. Arch Surg 1990;125:636–40.

    PubMed  Google Scholar 

  8. Furst MB, Stromberg BV, Blatchford GJ, Christensen MA, Thorson AG. Colonic anastomoses: bursting strength after corticosteroid treatment. Dis Colon Rectum 1994;37:12–5.

    PubMed  Google Scholar 

  9. Tjandra JJ, Fazio VW. Current status of ileo anal reservoirs. J ET Nurs 1993;220:56–62.

    Google Scholar 

  10. Wexner SD, Wong WD, Rothenberger DA, Goldberg SM. The ileoanal reservoir. Am J Surg 1990;159:178–83.

    PubMed  Google Scholar 

  11. Scott NA, Dozois RR, Beart RW Jr, Pemberton JH, Wolff BG, Ilstrup DM. Postoperative intra-abdominal and pelvic sepsis complicating ileal pouch-anal anastomosis. Int J Colorectal Dis 1988;3:149–52.

    PubMed  Google Scholar 

  12. Streeten DH. Corticosteroid therapy: II. Complications and therapeutic indications. JAMA 1975;232:1046–9.

    PubMed  Google Scholar 

  13. Dostal GH, Gamelli RL. The differential effect of corticosteroids on wound disruption strength in mice. Arch Surg 1990;125:636–40.

    PubMed  Google Scholar 

  14. Wise L, McAlister W, Stein T, Schuk P. Studies on the healing of anastomoses of small and large bowel intestines. Surg Gynecol Obstet 1975;141:190–4.

    PubMed  Google Scholar 

  15. Tjandra JJ, Fazio VW, Milsom JW, Lavery IC, Oakley JR, Fabre JM. Omission of temporary diversion in restorative proctocolectomy—is it safe? Dis Colon Rectum 1993;36:1007–14.

    PubMed  Google Scholar 

  16. Galandiuk S, Pemberton JH, Tsao J, Ilstrup DM, Wolff BG. Delayed ileal pouch-anal anastomosis: complications and functional results. Dis Colon Rectum 1991;34:755–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Read at the meeting of The American Society of Colon and Rectal Surgeons, Montreal, Quebec, Canada, May 7 to 12, 1995.

About this article

Cite this article

Ziv, Y., Church, J.M., Fazio, V.W. et al. Effect of systemic steroids on ileal pouch-anal anastomosis in patients with ulcerative colitis. Dis Colon Rectum 39, 504–508 (1996). https://doi.org/10.1007/BF02058701

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02058701

Key words

Navigation